Molecular and Genetic Interactions between Obesity and Breast Cancer Risk
Molecular and genetic modifications in obesity risk to BC development. Molecular pathway changes in obesity, including increased insulin levels and development of insulin resistance, inducing the synthesis of insulin growth factors I and II (IGF-I, IGF-II), inflammation reactions, and their imbalanced levels of adipokines and cytokines and expression of leptin receptor LEPR and adiponectin receptor ADIPOR1-2. The high aromatization reactions in the fat tissues lead to the high production of estrogen hormone. High levels of cholesterol synthesis are regulated by transcription faction sterol regulated element binding protein-2 (SERP-2, SERP-1). Downstream activation of molecular changes such as Janus kinase/signal transducer and activator of transcription 3 (JAK/STAT3), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase/v-Akt murine thymoma viral oncogene homolog/mammalian target of rapamycin (PI3K/Akt/mTOR occur. The molecular changes induce epigenetic alterations and single nucleotide polymorphism (SNP) risk. All these biological modifications induce BC development. The illustration was created with BioRender.com, Toronto, Canda.